Savara Inc. is a biopharmaceutical company headquartered in Austin, Texas, focused on developing innovative therapies for patients with rare lung diseases. With a commitment to addressing unmet medical needs in the field of respiratory health, Savara's pipeline includes promising candidates targeting various orphan indications. The company's strategic approach combines cutting-edge science with a patient-centric vision, positioning it as a key player in the lung disease therapeutic landscape.